Eventide Asset Management - Q3 2018 holdings

$2.72 Billion is the total value of Eventide Asset Management's 145 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 17.4% .

 Value Shares↓ Weighting
ASND BuyASCENDIS PHARMA A Ssponsored adr$109,472,000
+18.7%
1,544,900
+11.4%
4.02%
+5.0%
SRPT BuySAREPTA THERAPEUTICS INC$100,136,000
+102.0%
620,000
+65.3%
3.68%
+78.8%
XPO  XPO LOGISTICS INC$89,966,000
+14.0%
788,0000.0%3.30%
+0.9%
SEND NewSENDGRID INC$72,427,0001,968,653
+100.0%
2.66%
SAGE BuySAGE THERAPEUTICS INC$69,778,000
+20.5%
494,000
+33.5%
2.56%
+6.6%
LOW  LOWES COS INC$64,873,000
+20.1%
565,0000.0%2.38%
+6.3%
VRTX BuyVERTEX PHARMACEUTICALS INC$60,328,000
+46.1%
313,000
+28.8%
2.22%
+29.3%
W SellWAYFAIR INCcl a$59,068,000
-20.5%
400,000
-36.1%
2.17%
-29.7%
ZGNX BuyZOGENIX INC$58,716,000
+177.9%
1,183,792
+147.7%
2.16%
+145.8%
MYOV BuyMYOVANT SCIENCES LTD$56,153,000
+53.3%
2,115,000
+32.1%
2.06%
+35.7%
SPLK  SPLUNK INC$54,772,000
+22.0%
453,0000.0%2.01%
+7.9%
TTD  THE TRADE DESK INC$54,328,000
+60.9%
360,0000.0%2.00%
+42.4%
VRNS BuyVARONIS SYS INC$53,399,000
+40.7%
729,000
+43.1%
1.96%
+24.5%
HUBS  HUBSPOT INC$52,833,000
+20.4%
350,0000.0%1.94%
+6.5%
AIMT BuyAIMMUNE THERAPEUTICS INC$47,440,000
+8.9%
1,739,000
+7.3%
1.74%
-3.7%
MIC SellMACQUARIE INFRASTRUCTURE COR$47,422,000
+8.9%
1,028,000
-0.4%
1.74%
-3.6%
PANW  PALO ALTO NETWORKS INC$46,854,000
+9.6%
208,0000.0%1.72%
-3.0%
AVRO  AVROBIO INC$46,421,000
+81.6%
928,8910.0%1.70%
+60.7%
ALTR NewALTAIR ENGR INC$43,450,0001,000,000
+100.0%
1.60%
WCN  WASTE CONNECTIONS INC$41,241,000
+6.0%
517,0000.0%1.52%
-6.2%
BLUE  BLUEBIRD BIO INC$40,530,000
-7.0%
277,6030.0%1.49%
-17.7%
LOXO  LOXO ONCOLOGY INC$39,120,000
-1.5%
229,0000.0%1.44%
-12.9%
FIVN  FIVE9 INC$39,059,000
+26.4%
894,0000.0%1.43%
+11.8%
NEP SellNEXTERA ENERGY PARTNERS LP$38,776,000
+3.1%
799,500
-0.8%
1.42%
-8.8%
KAR  KAR AUCTION SVCS INC$36,411,000
+8.9%
610,0000.0%1.34%
-3.6%
LRCX  LAM RESEARCH CORP$34,436,000
-12.2%
227,0000.0%1.26%
-22.3%
STLD  STEEL DYNAMICS INC$34,073,000
-1.7%
754,0000.0%1.25%
-13.0%
CCI  CROWN CASTLE INTL CORP NEW$33,956,000
+3.3%
305,0000.0%1.25%
-8.6%
COLL  COLLEGIUM PHARMACEUTICAL INC$32,540,000
-38.2%
2,207,6100.0%1.20%
-45.3%
ASML  ASML HOLDING N V$32,339,000
-5.0%
172,0000.0%1.19%
-15.9%
MGA SellMAGNA INTL INC$32,238,000
-9.8%
613,700
-0.1%
1.18%
-20.1%
STKL  SUNOPTA INC$31,609,000
-12.5%
4,300,5400.0%1.16%
-22.5%
WBC  WABCO HLDGS INC$30,145,000
+0.8%
255,6000.0%1.11%
-10.8%
INST SellINSTRUCTURE INC$28,525,000
-28.8%
805,796
-14.5%
1.05%
-37.0%
LEA  LEAR CORP$26,680,000
-22.0%
184,0000.0%0.98%
-30.9%
MGTA BuyMAGENTA THERAPEUTICS INC$26,256,000
-11.0%
2,238,089
+0.0%
0.96%
-21.3%
ANAB BuyANAPTYSBIO INC$26,167,000
+411.6%
262,275
+264.3%
0.96%
+353.3%
LII  LENNOX INTL INC$25,771,000
+9.1%
118,0000.0%0.95%
-3.5%
ROP  ROPER TECHNOLOGIES INC$25,770,000
+7.4%
87,0000.0%0.95%
-5.0%
ARGX BuyARGENX SEsponsored adr$25,406,000
+206.6%
335,000
+235.0%
0.93%
+171.2%
ECYT BuyENDOCYTE INC$23,337,000
+383.2%
1,314,000
+275.4%
0.86%
+328.5%
APTV BuyAPTIV PLC$22,619,000
-4.8%
269,600
+4.0%
0.83%
-15.7%
BPMC BuyBLUEPRINT MEDICINES CORP$22,013,000
+131.2%
282,000
+88.0%
0.81%
+104.6%
PEGI BuyPATTERN ENERGY GROUP INCcl a$21,171,000
+6.2%
1,065,500
+0.2%
0.78%
-6.0%
IPHI  INPHI CORP$21,079,000
+16.5%
555,0000.0%0.77%
+3.1%
QURE SellUNIQURE NV$20,731,000
-27.3%
569,700
-24.4%
0.76%
-35.7%
VCYT  VERACYTE INC$20,375,000
+2.2%
2,133,5000.0%0.75%
-9.6%
KALV  KALVISTA PHARMACEUTICALS INC$19,899,000
+172.3%
900,0000.0%0.73%
+141.3%
MYOK  MYOKARDIA INC$19,690,000
+31.3%
302,0000.0%0.72%
+16.2%
NBIX  NEUROCRINE BIOSCIENCES INC$19,180,000
+25.2%
156,0000.0%0.70%
+10.7%
GTTN  GTT COMMUNICATIONS INC$19,139,000
-3.6%
441,0000.0%0.70%
-14.7%
MNTA BuyMOMENTA PHARMACEUTICALS INC$19,068,000
+110.0%
725,000
+63.3%
0.70%
+85.7%
SLDB  SOLID BIOSCIENCES INC$18,872,000
+32.4%
400,0000.0%0.69%
+17.3%
STRO NewSUTRO BIOPHARMA INC$18,134,0001,244,895
+100.0%
0.67%
STML  STEMLINE THERAPEUTICS INC$18,034,000
+3.4%
1,086,4000.0%0.66%
-8.6%
AY BuyATLANTICA YIELD PLC$17,822,000
+2.2%
866,000
+0.2%
0.66%
-9.5%
MTD  METTLER TOLEDO INTERNATIONAL$17,660,000
+5.2%
29,0000.0%0.65%
-6.8%
ANET  ARISTA NETWORKS INC$17,547,000
+3.3%
66,0000.0%0.64%
-8.7%
SNA SellSNAP ON INC$16,891,000
+11.2%
92,000
-2.6%
0.62%
-1.6%
PFPT  PROOFPOINT INC$16,800,000
-7.8%
158,0000.0%0.62%
-18.4%
HASI BuyHANNON ARMSTRONG SUST INFR C$16,145,000
+10.6%
752,000
+1.8%
0.59%
-2.1%
PAYC  PAYCOM SOFTWARE INC$14,919,000
+57.2%
96,0000.0%0.55%
+39.1%
IMMU  IMMUNOMEDICS INC$14,560,000
-12.0%
699,0000.0%0.54%
-22.1%
CRUS  CIRRUS LOGIC INC$14,282,000
+0.7%
370,0000.0%0.52%
-10.9%
VKTX NewVIKING THERAPEUTICS INC$13,762,000790,000
+100.0%
0.50%
VYGR  VOYAGER THERAPEUTICS INC$13,309,000
-3.2%
703,4250.0%0.49%
-14.2%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$12,800,000
+81.2%
132,000
+76.0%
0.47%
+60.4%
VMC  VULCAN MATLS CO$12,232,000
-13.8%
110,0000.0%0.45%
-23.8%
SGEN SellSEATTLE GENETICS INC$11,722,000
-68.3%
152,000
-72.7%
0.43%
-72.0%
PTCT BuyPTC THERAPEUTICS INC$11,468,000
+398.6%
244,000
+257.8%
0.42%
+343.2%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$11,040,000
+10.0%
294,000
+15.7%
0.40%
-2.9%
GWPH  GW PHARMACEUTICALS PLCads$10,969,000
+23.8%
63,5000.0%0.40%
+9.5%
BOLD  AUDENTES THERAPEUTICS INC$10,887,000
+3.6%
275,0000.0%0.40%
-8.3%
DOOR  MASONITE INTL CORP NEW$10,897,000
-10.8%
170,0000.0%0.40%
-21.1%
CELG SellCELGENE CORP$10,739,000
-62.5%
120,000
-66.8%
0.39%
-66.9%
EXAS  EXACT SCIENCES CORP$10,339,000
+32.0%
131,0000.0%0.38%
+16.9%
RCKT  ROCKET PHARMACEUTICALS INC$9,715,000
+25.4%
394,5850.0%0.36%
+11.2%
IFRX  INFLARX NV$9,438,000
+6.4%
275,0000.0%0.35%
-5.7%
REGN  REGENERON PHARMACEUTICALS$9,293,000
+17.1%
23,0000.0%0.34%
+3.6%
XNCR  XENCOR INC$8,885,000
+5.3%
228,0000.0%0.33%
-6.9%
GBT NewGLOBAL BLOOD THERAPEUTICS IN$8,740,000230,000
+100.0%
0.32%
WVE SellWAVE LIFE SCIENCES LTD$8,520,000
-31.8%
170,400
-47.8%
0.31%
-39.6%
FOLD NewAMICUS THERAPEUTICS INC$8,463,000700,000
+100.0%
0.31%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$8,135,000
+58.2%
319,000
+7.6%
0.30%
+40.4%
ETTX NewENTASIS THERAPEUTICS HLDGS I$8,140,000772,556
+100.0%
0.30%
BCRX NewBIOCRYST PHARMACEUTICALS$7,989,0001,047,000
+100.0%
0.29%
INCY  INCYTE CORP$7,944,000
+3.1%
115,0000.0%0.29%
-8.8%
XLRN SellACCELERON PHARMA INC$7,377,000
-71.3%
128,900
-75.7%
0.27%
-74.6%
UROV NewUROVANT SCIENCES LTD$7,138,000594,816
+100.0%
0.26%
MDGL SellMADRIGAL PHARMACEUTICALS INC$7,066,000
-45.1%
33,000
-28.3%
0.26%
-51.5%
RARX  RA PHARMACEUTICALS INC$7,019,000
+81.8%
388,0000.0%0.26%
+61.2%
CERN  CERNER CORP$6,969,000
+7.7%
108,2000.0%0.26%
-4.5%
EXR  EXTRA SPACE STORAGE INC$6,931,000
-13.2%
80,0000.0%0.26%
-23.0%
RARE  ULTRAGENYX PHARMACEUTICAL IN$6,672,000
-0.7%
87,4000.0%0.24%
-12.2%
SUPN  SUPERNUS PHARMACEUTICALS INC$6,546,000
-15.9%
130,0000.0%0.24%
-25.7%
RGEN  REPLIGEN CORP$6,101,000
+17.9%
110,0000.0%0.22%
+4.2%
FENC  FENNEC PHARMACEUTICALS INC$6,078,000
-21.5%
741,1750.0%0.22%
-30.5%
AGIO SellAGIOS PHARMACEUTICALS INC$5,784,000
-61.4%
75,000
-57.9%
0.21%
-65.9%
ALNY  ALNYLAM PHARMACEUTICALS INC$5,426,000
-11.1%
62,0000.0%0.20%
-21.3%
SNSS  SUNESIS PHARMACEUTICALS INC$4,531,000
-5.7%
2,265,4550.0%0.17%
-16.6%
GLPG  GALAPAGOS NVspon adr$4,497,000
+22.0%
40,0000.0%0.16%
+7.8%
VBIV  VBI VACCINES INC$4,477,000
-12.0%
1,850,0000.0%0.16%
-22.3%
XENE NewXENON PHARMACEUTICALS INC$4,158,000315,000
+100.0%
0.15%
DERM  DERMIRA INC$3,641,000
+18.5%
334,0000.0%0.13%
+4.7%
IRWD  IRONWOOD PHARMACEUTICALS INC$3,544,000
-3.5%
192,0000.0%0.13%
-14.5%
CRNX NewCRINETICS PHARMACEUTICALS IN$3,530,000123,225
+100.0%
0.13%
MGNX  MACROGENICS INC$3,152,000
+3.8%
147,0000.0%0.12%
-7.9%
IOVA  IOVANCE BIOTHERAPEUTICS INC$3,150,000
-12.1%
280,0000.0%0.12%
-22.1%
BEP BuyBROOKFIELD RENEWABLE PARTNERpartnership unit$3,115,000
+1.6%
103,000
+1.0%
0.11%
-10.2%
ABB BuyABB LTDsponsored adr$2,918,000
+21.3%
123,500
+11.8%
0.11%
+7.0%
CBIO  CATALYST BIOSCIENCES INC$2,652,000
-7.6%
246,0000.0%0.10%
-18.5%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored adr$2,628,000
+20.8%
59,5000.0%0.10%
+7.8%
FHB BuyFIRST HAWAIIAN INC$2,526,000
-5.9%
93,000
+0.5%
0.09%
-16.2%
HMC BuyHONDA MOTOR LTD$2,391,000
+7.5%
79,500
+4.6%
0.09%
-4.3%
JCI SellJOHNSON CTLS INTL PLC$2,170,000
-3.9%
62,000
-8.1%
0.08%
-14.9%
ETN SellEATON CORP PLC$2,090,000
+14.1%
24,100
-1.6%
0.08%
+1.3%
TERP BuyTERRAFORM PWR INC$2,079,000
+43.9%
180,000
+45.7%
0.08%
+26.7%
BG BuyBUNGE LIMITED$1,958,000
+2.1%
28,500
+3.6%
0.07%
-10.0%
BDN  BRANDYWINE RLTY TRsh ben int new$1,800,000
-6.9%
114,5000.0%0.07%
-17.5%
SYRS  SYROS PHARMACEUTICALS INC$1,787,000
+16.6%
150,0000.0%0.07%
+3.1%
MLHR BuyMILLER HERMAN INC$1,728,000
+15.8%
45,000
+2.3%
0.06%
+1.6%
SEP SellSPECTRA ENERGY PARTNERS LP$1,678,000
-21.0%
47,000
-21.7%
0.06%
-29.5%
DLPH  DELPHI TECHNOLOGIES PLC$1,652,000
-31.0%
52,6660.0%0.06%
-38.4%
GPMT BuyGRANITE PT MTG TR INC$1,668,000
+10.8%
86,500
+5.5%
0.06%
-1.6%
ALLK NewALLAKOS INC$1,575,00035,000
+100.0%
0.06%
EPIX SellESSA PHARMA INC$1,494,000
-18.0%
481,970
-0.0%
0.06%
-27.6%
CCIPRA  CROWN CASTLE INTL CORP NEW6.875% con pfd a$1,472,000
+2.0%
1,3550.0%0.05%
-10.0%
BuyHANNON ARMSTRONG SUST INFR Cnote 4.125% 9/0$1,361,000
+5.7%
1,394,000
+4.3%
0.05%
-5.7%
APU BuyAMERIGAS PARTNERS L Punit l p int$1,304,000
-3.5%
33,000
+3.1%
0.05%
-14.3%
CVA  COVANTA HLDG CORP$1,276,000
-1.5%
78,5000.0%0.05%
-13.0%
ARE BuyALEXANDRIA REAL ESTATE EQ IN$1,258,000
+4.9%
10,000
+5.3%
0.05%
-8.0%
VTR  VENTAS INC$1,169,000
-4.5%
21,5000.0%0.04%
-15.7%
CWEN NewCLEARWAY ENERGY INCcl c$1,174,00061,000
+100.0%
0.04%
ERIC  ERICSSONadr b sek 10$1,078,000
+14.7%
122,5000.0%0.04%
+2.6%
WELL SellWELLTOWER INC$1,036,000
-6.1%
16,100
-8.5%
0.04%
-17.4%
PLD  PROLOGIS INC$1,017,000
+3.2%
15,0000.0%0.04%
-9.8%
CIG BuyCOMPANHIA ENERGETICA DE MINAsp adr n-v pfd$881,000
+10.1%
515,000
+18.4%
0.03%
-3.0%
IR  INGERSOLL-RAND PLC$757,000
+14.0%
7,4000.0%0.03%0.0%
LPT SellLIBERTY PPTY TRsh ben int$655,000
-15.6%
15,500
-11.4%
0.02%
-25.0%
LXP  LEXINGTON REALTY TRUST$664,000
-4.9%
80,0000.0%0.02%
-17.2%
BuyDERMIRA INCnote 3.000% 5/1$584,000
+41.4%
700,000
+40.0%
0.02%
+23.5%
PSA  PUBLIC STORAGE$403,000
-11.2%
2,0000.0%0.02%
-21.1%
ABBV SellABBVIE INC$378,000
-99.1%
4,000
-99.1%
0.01%
-99.2%
 ACORDA THERAPEUTICS INCnote 1.750% 6/1$340,000
-12.6%
400,0000.0%0.01%
-25.0%
 HERCULES CAPITAL INCdbcv 4.375% 2/0$194,000
-3.0%
200,0000.0%0.01%
-12.5%
VICL ExitVICAL INC$0-300,000
-100.0%
-0.01%
EIGR ExitEIGER BIOPHARMACEUTICALS INC$0-36,000
-100.0%
-0.02%
AYI ExitACUITY BRANDS INC$0-6,850
-100.0%
-0.03%
NYLD ExitNRG YIELD INCcl c$0-61,000
-100.0%
-0.04%
TSRO ExitTESARO INC$0-26,000
-100.0%
-0.05%
ACAD ExitACADIA PHARMACEUTICALS INC$0-113,600
-100.0%
-0.07%
DBVT ExitDBV TECHNOLOGIES S Asponsored adr$0-170,000
-100.0%
-0.14%
EIDX ExitEIDOS THERAPEUTICS INC$0-162,000
-100.0%
-0.14%
JELD ExitJELD-WEN HLDG INC$0-700,000
-100.0%
-0.83%
ARW ExitARROW ELECTRS INC$0-295,000
-100.0%
-0.92%
ELLI ExitELLIE MAE INC$0-242,000
-100.0%
-1.04%
IDTI ExitINTEGRATED DEVICE TECHNOLOGY$0-826,000
-100.0%
-1.09%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-11-14
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings